Source: UncoverDC Host: Daniel Bobinski

video

When Dr. Vladimir Zelenko reached out to the White House with his discovery that a pre-hospital treatment of zinc, hydroxychloroquine, and azithromycin reduced by 84 percent the number of his Covid patients needing to be admitted to the hospital, it was hailed as a treatment that could save hundreds of thousands of lives.

President Trump touted the treatment as a “game changer,” but certain factions had other plans. The President’s enemies didn’t want him to get a win.

Anthony Fauci, a member of the Leadership Advisory Team for the Bill & Melinda Gates’ Foundation’s “Decade of Vaccines,” immediately downplayed the treatment and pushed for a vaccine instead – without ever disclosing his conflict of interest.

Next thing you knew, a drug that is sold over the counter in many countries and has been prescribed nearly 100 million times in 65 years was suddenly reported as deadly. And people believed it.

What really happened in the medical community has not been made known by the legacy media – but in this interview you will be exposed to the truth. Dr. Zelenko explains what happened, offers his ideas on why it happened, and what the motivations have been. He also explains the Zelenko protocol and how it works.

Share this interview with everyone you love so they can hear the truth – and get information that very well may save their lives.

See Dr. Zelenko’s recommended treatments and dosing:
Dr. Zelenko’s website: http://www.VladimirZelenkoMD.com

Link to Zelenko’s peer-reviewed paper on early risk-stratified treatment of zinc plus low-dose hcq and azithromycin (International Journal of Antimicrobial Agents)
https://www.sciencedirect.com/science/article/pii/S0924857920304258






Related: COVID-19 outpatients – early risk-stratified treatment with zinc plus low dose hydroxychloroquine and azithromycin: a retrospective case series study

‘Only a one in 17 billion chance hydroxychloroquine doesn’t work’: medical professor

Low Dose Hydroxychloroquine is Associated with Lower Mortality in COVID-19: A Meta-Analysis of 27 Studies and 44,684 Patients

Top US medics recommend ‘sequenced multidrug therapy’ including HCQ & Ivermectin, for early high-risk COVID-19 infections

Epidemiologist At Yale Provides Testimony On Hydroxychloroquine For Treating COVID-19

The AMA Quietly Admits They Lied About Hydroxychloroquine

Share on facebook
Share on twitter
Share on whatsapp
On Trend

Latest Stories

American Hero: Ralph C. Lorigo Fights for Client Rights Including Access to Ivermectin for COVID-19 Patients At Risk

Lorigo shared with TrialSite that once doctors learn of all of the studies around the world, and start doing their own homework, they become more open-minded, factoring in the risk-reward analysis. Especially if elderly high risk patients present advanced COVID-19, Lorigo has personally seen the drug potentially contribute to saving the lives of clients. Interestingly, the attorney reports that it would appear that hospital administrations are the most recalcitrant to the idea, even if the patients and the ICU doctor are in support.

Read More »